Related Experiment Videos
Tumor vaccines
1Tenovus Laboratory, Southampton General Hospital, United Kingdom.
Abstract:
Vaccination against tumor, either as a prophylactic procedure or as a mode of treatment, has been a distant goal of immunologists for many years. Ideally, the less specific therapies such as chemotherapy would be replaced by an anti-tumor immune response in the host that would be present on a continuing basis. However, progress has been hampered by a lack of understanding of the role of viruses in human tumor development and the molecular nature of tumor-associated antigens. Recent developments using the techniques of molecular biology and monoclonal antibody reagents are beginning to remedy this deficiency so that vaccination has become a real possibility for certain human cancers. The natural fluctuations in growth rates of some human tumors, and the observation that tumors can occasionally remain dormant for years, has led to the idea that the host has an intrinsic ability to control tumor growth, and that this ability is a property of the immune system. Attempts to enhance this putative control are being made by treating the host with defined biological modifiers that stimulate cells involved in immunity in vivo, and by seeking and expanding such cells in vitro before reinfusing them into the host. These attempts to harness the immune system to attack tumor cells that have evaded the host's defenses might be considered optimistic, but they will at least tell us a great deal about tumor cell behavior and the ability of the host to influence it.
Insights
Harnessing the immune system for cancer vaccination is a long-term goal. Advances in molecular biology and immunology are making anti-tumor immune responses a tangible possibility for treating certain human cancers.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Cancer vaccination has been a long-standing objective in immunology.
- Replacing traditional therapies like chemotherapy with sustained anti-tumor immune responses is ideal.
- Progress has been hindered by limited understanding of viral roles in human cancer and tumor-associated antigens.
Purpose of the Study:
- To explore the potential of cancer vaccination as a prophylactic or therapeutic strategy.
- To investigate methods for enhancing the host's intrinsic ability to control tumor growth.
- To leverage advancements in molecular biology and monoclonal antibody technology for cancer treatment.
Main Methods:
- Utilizing molecular biology techniques and monoclonal antibody reagents.
- Stimulating immune cells in vivo with biological modifiers.
- Expanding immune cells in vitro for reinfusion into the host.
Main Results:
- Recent developments indicate that cancer vaccination is becoming a realistic option for specific human cancers.
- The host's immune system possesses an intrinsic capacity to control tumor growth, evidenced by tumor dormancy and growth rate fluctuations.
- Research is actively exploring ways to enhance this natural immune control.
Conclusions:
- Cancer vaccination is emerging as a viable therapeutic avenue for certain cancers.
- Understanding tumor-associated antigens and viral roles is crucial for advancing anti-tumor immunity.
- Harnessing and enhancing the host immune system offers a promising, albeit optimistic, approach to cancer treatment and understanding tumor biology.